Polaris Venture Partners Special Founders' Fund V, L.P., 10% Owner at FATE THERAPEUTICS INC (FATE), bought 2,164,238 shares at $6.00 ($5.8M) on 2013-10-04, disclosed to the SEC on 2013-10-07.
Open-market purchase of $5.8M FATE by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,202,459 | $0 | 0.0% |
| 2 | $6.00 | 849 | $5K | 0.1% |
| 3 | $6.00 | 1,239 | $7K | 0.1% |
| 4 | $6.00 | 2,415 | $14K | 0.3% |
| 5 | $6.00 | 5,508 | $33K | 0.6% |
| 6 | $6.00 | 8,041 |
| $48K |
| 0.8% |
| 7 | $6.00 | 15,672 | $94K | 1.6% |
| 8 | $6.00 | 123,943 | $744K | 12.9% |
| 9 | $6.00 | 804,112 | $4.8M | 83.6% |
| Total | $2.67 avg | 2,164,238 | $5.8M | 100% |
| Filing → |
| GNCA | SELL | 2015-06-17 | $747K | — | Filing → |
| TRVN | BUY | 2014-02-07 | $3.3M | — | Filing → |